Characterizing drug resistance in hypoxia-adapted chronic myeloid leukaemia cells.

The development of tyrosine kinase inhibitors (TKI) has improved treatment of chronic myeloid leukaemia (CML) but resistance is observed in patients with advanced-stage CML. Second-generation TKIs overcome most resistance mechanisms but are ineffective against quiescent and hypoxic CML stem cells. M...

Full description

Saved in:
Bibliographic Details
Main Author: Muhammad Rauzan Rafman.
Other Authors: School of Biological Sciences
Format: Final Year Project
Language:English
Published: 2013
Subjects:
Online Access:http://hdl.handle.net/10356/52743
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English